CN1370570A - Medicine compoistion for traeting burns and scalds - Google Patents
Medicine compoistion for traeting burns and scalds Download PDFInfo
- Publication number
- CN1370570A CN1370570A CN 01107835 CN01107835A CN1370570A CN 1370570 A CN1370570 A CN 1370570A CN 01107835 CN01107835 CN 01107835 CN 01107835 A CN01107835 A CN 01107835A CN 1370570 A CN1370570 A CN 1370570A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- pharmaceutical composition
- rhizoma
- radix
- burn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The medicine composition for treating burns and scalds is compounded by using Rhizoma Atractylodis, Rhizoma Coptidis, diverse wormwood herb, garden burnet, frankincense and other Chinese medicinal materials and through crushing and mixing with sesame oil. When painted to wound part the said composition has high curative effect, less infection and no scar left.
Description
The invention provides a kind of pharmaceutical composition, especially a kind of pharmaceutical composition that scalds burn for the treatment of.
Boiling hot burn is a disease comparatively thorny in a kind of clinical surgery.Burning accident constantly takes place to scald in the daily life.The existing burn class medicine curative effect of scalding is not too satisfactory, and is more with rehabilitation stage complication during the treatment, is difficult to expect and control.As being prone to shock, infection etc. during the treatment of the boiling hot burn wound of moderate, even multiple organs failure appears, many after the rehabilitation with scar hyperplasia, thermoregulation dysfunction, wound surface pruritus pain, scar ulcer etc., the dark above wound surface healing time of II degree is long, expense is high, so-called " residual wound " appears in Chang Fanfu, need repeatedly carry out skin grafting and could cure.
The object of the present invention is to provide a kind of pharmaceutical composition that scalds burn for the treatment of, to improve the therapeutic effect that scalds burn.
The present invention is achieved in that the pharmaceutical composition of the boiling hot burn of treatment, it is characterized in that the proportioning raw materials of described pharmaceutical composition is:
Rhizoma Atractylodis 120～180 weight portions
Rhizoma Coptidis 30～90 weight portions
Herba Artemisiae Anomalae 130～200 weight portions
Radix Sanguisorbae 150～210 weight portions
Olibanum 30～90 weight portions
Myrrha 30～90 weight portions
Cortex Phellodendri 100～160 weight portions
Radix Et Rhizoma Rhei 150～200 weight portions
Rhizoma Polygoni Cuspidati 130～190 weight portions
Borneolum Syntheticum 15～45 weight portions
Radix Glycyrrhizae 20～60 weight portions
Wherein Olibanum, Myrrha do not add any adjuvant earlier, after frying itself and other nine flavor raw materials are ground altogether to 120 order fine powders.Time spent, the fine powder of per 100 weight portion above-mentioned raw materials adds 150 weight portion Oleum Ricini, mixes well.
The pharmaceutical composition of burn is scalded in this treatment, and pain relieving is fast, does not generally infect in the therapeutic process, does not also generally produce cicatrix after healing, and therapeutic effect is good, and is easy to use.
Further specify the present invention below.
The optimum ratio that the raw material of the pharmaceutical composition of burning is scalded in the present invention's treatment is:
Rhizoma Atractylodis 140～160 weight portions
Rhizoma Coptidis 55～65 weight portions
Herba Artemisiae Anomalae 140～160 weight portions
Radix Sanguisorbae 180～200 weight portions
Olibanum 35～50 weight portions
Myrrha 35～50 weight portions
Cortex Phellodendri 140～160 weight portions
Radix Et Rhizoma Rhei 150～160 weight portions
Rhizoma Polygoni Cuspidati 150～160 weight portions
Borneolum Syntheticum 25～35 weight portions
Radix Glycyrrhizae 40～50 weight portions
The best proportioning that the raw material of the pharmaceutical composition of burning is scalded in the present invention's treatment is:
Rhizoma Atractylodis 150 weight portions
Rhizoma Coptidis 60 weight portions
Herba Artemisiae Anomalae 150 weight portions
Radix Sanguisorbae 180 weight portions
Olibanum 40 weight portions
Myrrha 40 weight portions
Cortex Phellodendri 150 weight portions
Radix Et Rhizoma Rhei 150 weight portions
Rhizoma Polygoni Cuspidati 150 weight portions
Borneolum Syntheticum 30 weight portions
Radix Glycyrrhizae 45 weight portions
In the present invention's the pharmaceutical composition, Rhizoma Atractylodis, Cortex Phellodendri, Rhizoma Coptidis, Radix Et Rhizoma Rhei have heat clearing and damp drying, and the effect of eliminating fire and detoxication has very strong inhibitory action to staphylococcus, streptococcus, and bacillus pyocyaneus, Hemolytic streptococcus are had stronger inhibitory action.
In the present invention's the pharmaceutical composition, Rhizoma Polygoni Cuspidati, Borneolum Syntheticum, Olibanum, Myrrha have heat-clearing and toxic substances removing, heat radiation analgesic effect, and staphylococcus aureus, bacillus pyocyaneus are had strong inhibitory action.Also have convergence, anticorrosion, hemostasis, analgesic effect in addition.Olibanum, Myrrha also have stronger invigorating blood circulation analgesia effect.
In the present invention's the pharmaceutical composition, Herba Artemisiae Anomalae, Radix Sanguisorbae have the cooling blood for hemostasis effect, can reduce transudate, and staphylococcus aureus is had inhibitory action.
Radix Glycyrrhizae in the present invention's the pharmaceutical composition has heat-clearing and toxic substances removing, relieving spasm to stop pain, the effect of the above all medicines of blending.
The using method of the present invention's pharmaceutical composition is, clears up wound surface with normal saline earlier, and reuse 1% bromo geramine carries out disinfection to wound surface.Foaming person can wear out drawing liquid with aseptic syringe needle, but should protect skin complete as far as possible, not avulsion.The present invention's pharmaceutical composition is applied to wound surface.Thickness is about 0.5～3 millimeter.Once a day.If any wiping place's coating at any time.Not having when infection can use separately, has when infection can cooperate the penicillin and streptomycin transfusion, to strengthen antiinflammation.
It below is the clinical test results of the present invention's pharmaceutical composition.
Test group: treat with the present invention's pharmaceutical composition as stated above.The case sum has 128 examples, wherein male 79 examples, women 49 examples, the oldest 61 years old, minimum 1 years old.Matched group: use " JINGWANHONG " to treat by the conventional using method of " JINGWANHONG ".The case sum has 76 examples.Wherein male 46 examples, women 30 examples, the oldest 63 years old, minimum 1.5 years old.
Scald the burn degree and can carry out calibration by the present world habitual " three degree quarterings ".
The criterion of curative effect:
Excellent: as to be as good as substantially with normal skin, the no XOR of tissue.
Very: few cicatrix does not influence function, no residual wound substantially.
Can: cicatrix is arranged, influence function, residual wound is arranged.
Bad: disunion or death.
The curative effect of the present invention's pharmaceutical composition (test group) such as following table (each percent accounts for the percent of test group sum for it in the table).
| Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
| Shallow II degree | ????71 | ????52.3 | ????3.1 | ||
| Dark II degree | ????52 | ????6.2 | ????31.3 | ????3.1 | |
| The III degree | ????5 | ????3.1 | ????0.8 |
Curative effect of " JINGWANHONG " (matched group) such as following table (percent accounts for the percent of matched group case sum for it in the table).
| Case load | Excellent (%) | Very (%) | Can (%) | Bad (%) | |
| Shallow II degree | ????54 | ????9.2 | ????18.4 | ????25.0 | ????18.4 |
| Dark II degree | ????20 | ????2.6 | ????6.6 | ????17.1 | |
| The III degree | ????2 | ????2.6 |
Claims (3)
1, the pharmaceutical composition of burn is scalded in treatment, it is characterized in that the proportioning raw materials of described pharmaceutical composition is:
Rhizoma Atractylodis 120～180 weight portions
Rhizoma Coptidis 30～90 weight portions
Herba Artemisiae Anomalae 130～200 weight portions
Radix Sanguisorbae 150～210 weight portions
Olibanum 30～90 weight portions
Myrrha 30～90 weight portions
Cortex Phellodendri 100～160 weight portions
Radix Et Rhizoma Rhei 150～200 weight portions
Rhizoma Polygoni Cuspidati 130～190 weight portions
Borneolum Syntheticum 15～45 weight portions
Radix Glycyrrhizae 20～60 weight portions
2, the pharmaceutical composition of burn is scalded in treatment as claimed in claim, it is characterized in that the proportioning raw materials of described pharmaceutical composition is:
Rhizoma Atractylodis 140～160 weight portions
Rhizoma Coptidis 55～65 weight portions
Herba Artemisiae Anomalae 140～160 weight portions
Radix Sanguisorbae 180～200 weight portions
Olibanum 35～50 weight portions
Myrrha 35～50 weight portions
Cortex Phellodendri 140～160 weight portions
Radix Et Rhizoma Rhei 150～160 weight portions
Rhizoma Polygoni Cuspidati 150～160 weight portions
Borneolum Syntheticum 25～35 weight portions
Radix Glycyrrhizae 40～50 weight portions
3, the pharmaceutical composition of burn is scalded in treatment as claimed in claim 1, it is characterized in that the proportioning raw materials of described pharmaceutical composition is:
Rhizoma Atractylodis 150 weight portions
Rhizoma Coptidis 60 weight portions
Herba Artemisiae Anomalae 150 weight portions
Radix Sanguisorbae 180 weight portions
Olibanum 40 weight portions
Myrrha 40 weight portions
Cortex Phellodendri 150 weight portions
Radix Et Rhizoma Rhei 150 weight portions
Rhizoma Polygoni Cuspidati 150 weight portions
Borneolum Syntheticum 30 weight portions
Radix Glycyrrhizae 45 weight portions
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011078359A CN1164288C (en) | 2001-02-27 | 2001-02-27 | Medicine compoistion for traeting burns and scalds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011078359A CN1164288C (en) | 2001-02-27 | 2001-02-27 | Medicine compoistion for traeting burns and scalds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1370570A true CN1370570A (en) | 2002-09-25 |
| CN1164288C CN1164288C (en) | 2004-09-01 |
Family
ID=4656740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011078359A Expired - Fee Related CN1164288C (en) | 2001-02-27 | 2001-02-27 | Medicine compoistion for traeting burns and scalds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1164288C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100434102C (en) * | 2006-09-15 | 2008-11-19 | 吴艳东 | Medicine for treating scalds |
| CN102940714A (en) * | 2012-10-10 | 2013-02-27 | 肥西县中医院 | Traditional Chinese medicine composition for treating burn and preparation method |
| CN103735806A (en) * | 2013-12-26 | 2014-04-23 | 彭声义 | Traditional Chinese medicine for external application for treating scald and burn without scars |
| CN103735738A (en) * | 2013-12-26 | 2014-04-23 | 彭声义 | Traditional Chinese medicinal spray for treating scalds and burns without scar |
| CN104127581A (en) * | 2014-07-11 | 2014-11-05 | 庞东剑 | Formula and preparation method of external traditional Chinese medicine for treating burns |
| CN105596508A (en) * | 2016-01-27 | 2016-05-25 | 张银贵 | External application medicine powder for treating burns |
-
2001
- 2001-02-27 CN CNB011078359A patent/CN1164288C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100434102C (en) * | 2006-09-15 | 2008-11-19 | 吴艳东 | Medicine for treating scalds |
| CN102940714A (en) * | 2012-10-10 | 2013-02-27 | 肥西县中医院 | Traditional Chinese medicine composition for treating burn and preparation method |
| CN103735806A (en) * | 2013-12-26 | 2014-04-23 | 彭声义 | Traditional Chinese medicine for external application for treating scald and burn without scars |
| CN103735738A (en) * | 2013-12-26 | 2014-04-23 | 彭声义 | Traditional Chinese medicinal spray for treating scalds and burns without scar |
| CN104127581A (en) * | 2014-07-11 | 2014-11-05 | 庞东剑 | Formula and preparation method of external traditional Chinese medicine for treating burns |
| CN105596508A (en) * | 2016-01-27 | 2016-05-25 | 张银贵 | External application medicine powder for treating burns |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1164288C (en) | 2004-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1036120C (en) | Preparation method of medicine made of Chinese herbs for treatment of burns | |
| CN1923234A (en) | Traditional Chinese medicinal formulation for treating osteoarthropathy | |
| CN1739697A (en) | Externally applied ointment for treating burns and scalds | |
| CN1164288C (en) | Medicine compoistion for traeting burns and scalds | |
| CN1785335A (en) | Pure Chinese medicinal preparation for external treating burn and scald | |
| CN1088369C (en) | Moxibustion liquid --moxibustion fixing paste and its preparation method and use method | |
| CN1290533A (en) | Medicine powder | |
| CN1085797A (en) | Eliminating inflammation and expelling toxin sore treatment ointment and preparation method thereof | |
| CN1883575A (en) | Chinese medicine for treating hyperosteogeny | |
| CN1261140C (en) | Medicine for treating burns and scalds | |
| CN101066307A (en) | Burn treating medicine powder and its prepn | |
| CN1279952C (en) | Medicine for treating burn and scald | |
| CN1172700C (en) | External applied medicine for curing burn and preparing method thereof | |
| CN1444967A (en) | Chinese herbal medicine preparation for treating burns | |
| CN1476868A (en) | Ointment for external application for curing scald and burn | |
| CN1086955C (en) | Ointment for treating burn and scald and its preparing process | |
| CN1175850C (en) | Medicine for treating burns and scald, and producing method thereof | |
| CN1439413A (en) | Chinese medicine against skin and external diseases | |
| CN1257732C (en) | Medicine for treating mastosis and preparation process thereof | |
| CN115887601B (en) | A composition for treating hemorrhoid and its preparation method | |
| CN103127274A (en) | All-season burn and scald medicine for seasons | |
| CN1375306A (en) | Sanhuanggao ointment as externally used medicine for treating burns and scalds | |
| CN1055398C (en) | Medicament for treatment of hyerosteogeny and its prepn. | |
| CN107050298A (en) | A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged | |
| CN106511770A (en) | Traditional Chinese medicine preparation treating herpes zoster and preparing method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040901 Termination date: 20110227 |